News

The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.

The Centenary Institute’s 'When Art Meets Science' exhibition took centre stage at the recent launch of the annual Sydney Local Health District (SLHD) March Arts program.

Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell model demonstrating that the virus that causes COVID‑19 (SARS-CoV-2) can directly infect heart tissue, providing new insight into why some people experience serious heart complications during and after infection.

Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments.

Researchers at the Centenary Institute, Chris O’Brien Lifehouse, NSW Health Pathology and Royal Prince Alfred Hospital have found a potential new way to help doctors identify which head and neck cancer patients may be at higher risk of their cancer returning, using a simple blood test.

Researchers from the Centenary Institute have developed a new diagnostic tool, the FAP-Index, that could significantly improve how doctors identify people at risk of serious liver damage caused by metabolic fatty liver disease. The condition affects around one in three Australians with cases projected to increase by 25% to over 7 million by 2030.

Centenary researchers have been awarded funding to commercialise a first‑of‑its‑kind medical AI platform designed to improve treatment decisions and reduce unnecessary surgeries for Australian cancer patients. The project, funded through the Australian Government’s Australia’s Economic Accelerator (AEA) Ignite program and led by Dr Yagiz Aksoy, Senior Clinical Research Fellow at Centenary’s Centre for Biomedical AI, ...

The Centenary Institute and the University of Sydney have launched a major new initiative that brings next-generation spatial biology technologies together to transform how health threats such as cancer, cardiovascular diseases and infectious diseases are studied and understood.

The Centenary Institute is deeply saddened by the passing of our Founding Patron, Professor The Honourable Dame Marie Bashir AD CVO.

Centenary Institute researchers have achieved success in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants, securing funding for innovative work in rare genetic diseases and liver disease.

A major new research project funded by the Australian Research Council (ARC) Discovery Projects scheme is commencing, with the Centenary Institute playing a central role. The project will establish an advanced platform to improve therapeutic protein design, supporting future developments in drugs, diagnostics and biotechnology.

Centenary Institute researchers played a prominent role at the Australian Biology of Ageing Conference 2025 this week, contributing new scientific insights on how Australians can live healthier lives as they age.